Overview

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

Status:
COMPLETED
Trial end date:
2022-10-08
Target enrollment:
Participant gender:
Summary
This is a Phase I/II Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis.
Phase:
PHASE1
Details
Lead Sponsor:
Minghui Pharmaceutical (Hangzhou) Ltd
Treatments:
Ointments